The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHLAX | 35.05 | -0.19 | -0.54% |
PGIM Jennison Health Sciences A | |||
TRIFX | 4.89 | -0.05 | -1.01% |
Catalyst/SMH Total Return Income A | |||
AIMOX | 15.15 | -0.22 | -1.43% |
AQR International Momentum Style I | |||
TIGRX | 15.21 | -0.32 | -2.06% |
Nuveen Core Equity R6 | |||
BPSCX | 24.43 | -0.53 | -2.12% |
Boston Partners Small Cap Value II Inv |
A.I.dvisor indicates that over the last year, CHCLX has been closely correlated with FSMAX. These tickers have moved in lockstep 98% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHCLX jumps, then FSMAX could also see price increases.
Ticker / NAME | Correlation To CHCLX | 1D Price Change % | ||
---|---|---|---|---|
CHCLX | 100% | -3.60% | ||
FSMAX - CHCLX | 98% Closely correlated | -3.06% | ||
VMGIX - CHCLX | 93% Closely correlated | -2.79% | ||
VMGMX - CHCLX | 93% Closely correlated | -2.79% | ||
PEMGX - CHCLX | 84% Closely correlated | -1.70% | ||
PMBJX - CHCLX | 83% Closely correlated | -1.68% | ||
More |